Avenue Biosciences
Health
· Headquartered in Finland 🇫🇮
Website
HQ Country
🇫🇮 Finland
LinkedIn
Careers
No public jobs page
Track Avenue Biosciences
— get Health deals in free daily digest
Overview
Avenue Biosciences, a Finnish protein engineering company, has raised $5.7 million in a seed extension round co-led by Balnord and Tesi, with additional participation from Voima Ventures, Inventure, University of Helsinki, and Dimerent. The funding aims to enhance protein biogenesis efficiency in therapeutic protein production, addressing challenges in manufacturing complex proteins. The total funding since 2024 now stands at $8.7 million, leveraging research from the University of Helsinki.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: Balnord, Tesi, Voima Ventures, Inventure, University of Helsinki, Dimerent
Avenue Biosciences, a Finnish protein engineering company, has raised $5.7 million in a seed extension round co-led by Balnord and Tesi, with additional participation from Voima Ventures, Inventure, University of Helsinki, and Dimerent. The funding aims to enhance protein biogenesis efficiency in therapeutic protein production, addressing challenges in manufacturing complex proteins. The total funding since 2024 now stands at $8.7 million, leveraging research from the University of Helsinki.
More Health Deals
Market Map
View thousands of companies by category in our market map:
